Rentschler Biopharma SE
Overview
Rentschler Biopharma SE is a leading contract development and manufacturing organization (CDMO) focused on the development and manufacture of biopharmaceuticals. The company provides solutions for the entire value chain from gene to vial, helping pharmaceutical clients advance into clinical phases and commercialization.
Core services & business areas
Biopharmaceutical ManufacturingProcess DevelopmentScale-Up ProductionRegulatory SupportQuality Control
Therapeutic areas
FDA compliance signals
1 FDA enforcement record linked to this company.
- 4832016-12-06
Equipment Design, Size and Location
Verified Supplier Partner
Is this Rentschler Biopharma SE? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Catalent, Inc.
United States
Genzyme Corporation
United States
ICON Public Limited Company
Ireland
Regeneron Pharmaceuticals, Inc.
United States
Schering-Plough Corporation
United States
Zhejiang Hisun Pharmaceutical Co., Ltd.
China
C.H. Boehringer Sohn AG & Co. KG
Germany
Boehringer Mannheim Pharmaceuticals Corp. (now part of Roche)
Switzerland
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.